Martingale Asset Management L P Dynavax Technologies Corp Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$10.73 - $12.58 $82,621 - $96,866
-7,700 Reduced 40.5%
11,311 $127,000
Q1 2024

May 14, 2024
BUY
$11.7 - $14.98 $222,428 - $284,784
19,011 New
19,011 $235,000
Q2 2021

Aug 13, 2021
SELL
$7.25 - $10.99 $83,440 - $126,483
-11,509 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$4.57 - $11.18 $52,596 - $128,670
11,509 New
11,509 $113,000

Others Institutions Holding DVAX

# of Institutions
273
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.6B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email